Inherited disease Flashcards
Autosomal dominance
Myotonic dystrophy
Huntington disease
If parent A has genes 1+2 (1 faulty) and parent B has genes 3+4 (neither faulty) then possible outcomes are 1,3 1,4 2,3 2,4 - the possibilities with a 1 in are affected, thus 50% - in autosomal dominant you only need one faulty gene
Autosomal recessive
Sickle cell anaemia
Cystic fibrosis
If parent A has genes 1+2 (1 faulty) and parent B has genes 3+4 (4 faulty) then possible outcomes are 1,3 1,4 2,3 2,4 - 2 possibilities will only have 1 faulty gene (carriers), another will have none, but one will have 2 faulty genes and you need 2 in autosomal recessive, thus 25% of passing it on
X-linked Dominant
Fragile X
As in autosomal dominant inheritance, only one copy of a disease allele on the X chromosome is required
Both males and females can be affected, although males may be more severely affected because they only carry one copy of genes found on the X chromosome
When a female is affected there is 1 faulty X chromosome but she must pass on one of her X chromosomes so there is always a 50% chance of passing on to offspring, regardless of sex
When a father is affected there is 1 faulty X chromosome. If they have a girl then he MUST pass on his X chromosome and thus 100% of girls will have dominant disease. but if they have a boy then he MUST have passed on his healthy Y chromosome thus no disease
X-linked recessive
Duchenne muscular dystrophy
Hemophilia A
Any male with one faulty X chromosome will be affected as they only carry one X! (acts like dominant)
Carrier mother: 50% chance son will be affected (if he gets the one faulty X from mother)
50% chance daughter will be a carrier too
Affected mother:
100% of sons will be affected.
100% of daughters will be carriers
Affected father:
0% of boys are affected
100% of girls are carriers
Penetrance
Expression
What proportion of individuals with a gene mutation will manifest disease?
How does the disease express itself?
- Karyotype analysis
- FISH
- Array comparative genomic
hybridization (arrayCGH) - Multiplex ligation-dependent probe
amplification (MLPA)
- Chromosome changes - used for prenatal screening
- Specific probes looking for subtle translocations on chromosomes - used in Williams syndrome - replaced by real time PCR whole exome sequencing techniques
- Looks for loss and gain of genetic material - detects gene amplification in tumours and leukemia
- Variation of PCR - good for prenatal diagnosis
Incomplete penetrance
When an individual does not express the phenotype even though they carry the allele
Anticipation
Increased severity of phenotype when passed onto the next generation (Myotonic Dystrophy / Huntington’s)
Heterogeneity
One phenotype caused by a variety
of gene mutations (Limb Girdle Muscular Dystrophy)
Tall, slim, dilatation of aortic root, ascending aorta aneurysm, lens dislocation = which disease and inheritance
Marfan
AD
Most important annual monitoring Ix = ECHO
AD disease which caused by defect in FGFR3 and is sporadic 80% - Lannister from GoT
Achondroplasia
Edwards 18 (more letters = higher number)
Patau 13
Overriding fingers + clenched fist + low set ears + ‘rocker-bottom’ feet
Cleft lip + multiple fingers
Trisomy 21
Downs syndrome
Hypotonia, prominent epicathic folds, protruding tongue, Brushfields spots/whitish spots in iris, single transverse palmer crease
ASD, VSD, Fallot tetralogy, duodenal atresia
47XXY Klinefelters syndrome
Mechanism
Clinical
Dx
Kallmann: Low GnRH + anosmia
Additional X chromosome
Infertility and obesity
Hypergonadotrophic hypogonadism due to loss of testosterone + gynaecomastia
Low testosterone High GnRH
Karyoype test to diagnose
“A young man with learning disabilities is tall with additional secondary sexual characteristics, enlarged breasts and small testicles and penis.”
45X Turner syndrome
Mechanism
Clinical
Dx
Missing an X chromosome
Only females
Short statue, broad neck, widely spaced hypoplastic nipples, low posterior hairline, coarctation of the aorta and VSD,
HORSESHOE KIDNEY or unilateral
renal agenesis
OVARIAN AGENESIS/hypoplastic ‘streak’ ovaries
(primary amenorrhoea and infertility)
Karyoype test to diagnose
If its X linked dominant or recessive every ? will be affected as they only have one X
Boy
Duchenne Muscular Dytrophy
X-linked recessive
Frame-shift mutation > Nonsense mediated decay > ABSENCE of dystrophin = DMD
Gower sign (strange way of standing up), hypertrophic cardiomyopathy, behavioural issues, type 1 resp failure, live til 20s
Electromyography shows weakness is caused by destruction of muscle tissue rather than damage to nerves
Becker Muscular Dystrophy
X-linked recessive
Frame-shift mutation > Shortened dystrophin = BMD
Calf hypertrophy, cardiomyopathy, limb girdle wekness, raised CK, live til 60s
Dystrophinopathy pathophysiology
Dystrophin is responsible for connecting the
cytoskeleton of each muscle fiber to the
underlying basal lamina, through the
dystrophin glycoprotein complex.
Affects skeletal and cardiac muscle!
Absence of dystrophin → excess calcium
penetrates the sarcolemma →water enters
the mitochondria causing them to burst
Myotonic dystrophy
Features ANTICIPATION
Autosomal dominant
CTG repeat expansion in the DMPK gene 3-37 repeats = normal 50 = cataracts 200 = cataracts, muscle weakness, myotonia >1000 repeats = congenital form
Clue: Failure of spontaneous release of the hands following strong handshakes due to myotonia (delayed relaxation of muscles after contraction)
Angelman syndrome
Lack of expression of UBE3A gene on the maternally inherited chromosome 15, while the paternal copy is imprinted and thus silenced
DNA-based methylation testing diagnostic
Neurodevelopmental disorder
Jerky movements (hand flapping)
Frequent laughter and smiling
Affinity for water
Prader-Willi syndrome
P for lack of gene from paternal - then maternal is imprinted
Lack of expression of genes on the paternally inherited chromosome 15, while the maternal copy is imprinted
DNA-based methylation testing diagnostic
Slow development
Obesity - very hungry
T2DM
An activated oncogene causes ?
A defective tumour supressor causes ?
A defective DNA repair causes ?
Uncontrolled proliferation (MEN2 due to RET gene)
No apoptosis (Retinoblastoma)
No repair work done (NER defect = Xeroderma Pigmentosa) (OR HNPCC or BRCA1/2 breast-ovarian)
BRCA1 cancers
BRCA2 cancers
PTEN / Cowdens
P53 Li Fraumeni
Breast, ovary, fallopian tube
Breast, ovary, male breast, prostate, pancreas etc
Breast, thyroid
Breast sarcoma
Explain PARP inhibitors and how they work for triple negative breast cancer with BRCA gene mutations
One characteristic of BRCA-mutated cancers is defective function of one of the major DNA damage repair pathways, the homologous recombination (HR) pathway. The original concept of the activity of PARP inhibitors was that they acted through synthetic lethality by targeting the base excision repair pathway (BER); in tumor cells with defects in a different DNA repair mechanism, disruption of both pathways led to cell death
Breast cancer surveillance guidelines
National screening is with mammography 3 yearly 47-73y
TP53 mutation = annual MRI from 20-49 (may have until 69)
BRCA mutation = annual MRI +/- mammogram 30-49y then mammogram 50-69y
Mammography should not be used if <30y OR if dense breasts so mri if high risk or maybe ultrasound if low risk
Familial Adenomatous Polyposis
Autosomal dominant
Present as teenager
Loss of APC gene (tumour suppressor) > uncontrolled proliferation
1000s of polyps > colon ca by 40y
Skin, teeth and bone abnormalities - sebaceous cysts, jaw cysts, osteoma
Hereditary non-polyposis colon cancer
Lynch syndrome
Autosomal dominant
Present as adult
DNA mismatch repair defect / “mutator pathway”
Lifetime colon risk 80%
Risk of ENDOMETRIAL TOO!
Polyps may be absent
Microsatellite instability (Impaired ability to copy repetitive DNA sequences)